Atlas Trials

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

Clinical trial NCT00566345 · COMPLETED

Trial details

NCT number
NCT00566345
Sponsor
Alachua Government Services, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2007-11-01
Primary completion
2008-06-01
Enrollment
3670

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.